National Comprehensive Cancer Network



About NCCN

Breast Cancer Panel - Disclosures as of 11/29/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Craig Allred, MD

None

None

Clarient, Inc

None

3/28/2012

Benjamin O. Anderson, MD

None

Wyeth Pharmaceuticals

None

None

5/28/2012

Marian Birkeland

None

None

GlaxoSmithKline

None

11/19/2012

Harold J. Burstein, MD, PhD

None

None

None

None

5/3/2012

Robert W. Carlson, MD

None

Amgen Inc.;
Genentech, Inc.;
Pfizer Inc.

None

None

8/9/2012

W. Bradford Carter, MD

None

None

None

None

4/4/2011

Stephen B. Edge, MD

None

None

None

None

6/5/2012

John K. Erban, MD

None

Macrogenics;
Transmolecular, Inc

None

None

7/22/2009

William B. Farrar, MD

None

None

None

None

6/18/2012

Andres Forero, MD

Biogen Idec;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

5/5/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/5/2012

Sharon Hermes Giordano, MD, MPH

None

None

None

None

5/1/2012

Lori J. Goldstein, MD

None

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Bristol-Myers Squibb Company;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Pharmion Corporation;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

7/13/2012

William J. Gradishar, MD

None

Abraxis Bioscience, Inc.;
Bayer HealthCare;
Genentech, Inc.;
General Electric;
GlaxoSmithKline;
Onyx Pharmaceuticals, Inc.;
sanofi-aventis U.S.

None

None

1/21/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Daniel F. Hayes, MD

None

Chugai Pharmaceuticals;
Compendia Bioscience;
DNAR (DNA Repair, Boston, MA)

Halcyon Diagnostics, Inc;
Oncimmune LLC

None

6/6/2012

Clifford A. Hudis, MD

None

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Eisai Inc.;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

8/9/2012

Rashmi Kumar, PhD

None

None

None

None

2/15/2012

Britt-Marie E. Ljung, MD

National Cancer Institute

Versant ventures

None

None

1/31/2013

David A. Mankoff, MD, PhD

Merck & Co., Inc.;
Pfizer Inc.

Genzyme Corporation

None

None

7/7/2011

P. Kelly Marcom, MD

None

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.

None

None

6/20/2011

Ingrid A. Mayer, MD

None

None

None

None

10/1/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Beryl McCormick, MD

None

None

None

None

6/15/2012

Lori J. Pierce, MD

None

None

None

None

6/11/2012

Elizabeth C. Reed, MD

None

UnitedHealthcare

None

None

5/8/2012

Jasgit Sachdev, MD

None

Genomic Health, Inc.;
GlaxoSmithKline

None

None

7/1/2011

Dorothy Shead, MS

None

None

None

None

8/3/2012

Mary Lou Smith, JD, MBA

None

Eli Lilly and Company

None

None

2/1/2013

George Somlo, MD

None

Bristol-Myers Squibb Company;
Bristol-Myers Squibb Company;
Bristol-Myers Squibb Company;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Abraxane;
Roche Laboratories, Inc.

None

None

8/16/2012

John H. Ward, MD

None

None

None

None

1/17/2013

Antonio C. Wolff, MD

None

None

None

None

6/9/2012

Richard Zellars, MD

None

None

None

None

9/6/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved